The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL
Open accessAbstract
Summary In diffuse large B cell lymphoma (DLBCL), tumors belonging to the ABC but not GCB gene expression subgroup rely upon chronic active B cell receptor signaling for viability, a dependency that is targetable by ibrutinib. A phase III trial (“Phoenix”; NCT01855750) showed a survival benefit of ibrutinib addition to R-CHOP chemotherapy in younger patients with non-GCB DLBCL, but the molecular basis for this benefit was unclear. Analysis of biopsies from Phoenix trial patients revealed 3 previously characterized genetic subtypes of DLBCL: MCD, BN2 and N1. The 3-year event-free survival of younger patients (age≤60) treated with ibrutinib plus R-CHOP was 100% in the MCD and N1 subtypes while the survival of patients with these subtypes treated with R-CHOP alone was significantly inferior (42.9% and 50%, respectively). This work provides a mechanistic understanding of the benefit of ibrutinib addition to chemotherapy, supporting its use in younger patients with non-GCB DLBCL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Self-citationRosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
Self-citationHans, C. P. (2004) · Blood · doi:10.1182/blood-2003-05-1545 · Cited by 3,703
Wang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., & Baldwin, A. S. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,711
Genetics and pathogenesis of diffuse large B-cell lymphoma
Schmitz, R., Wright, G. W., Huang, D. W., Johnson, C. A., Phelan, J. D., Wang, J. Q., Roulland, S., Kasbekar, M., Young, R. M., Shaffer, A. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1801445 · Cited by 2,241
Self-citationAACR Project GENIE: Powering Precision Medicine through an International Consortium
The AACR Project GENIE Consortium, The AACR Project GENIE Consortium, André, F., Arnedos, M., Baras, A. S., Baselga, J., Bedard, P. L., Berger, M. F., Bierkens, M., Calvo, F., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0151 · Cited by 1,964
Chapuy, B., Stewart, C., Dunford, A. J., Kim, J., Kamburov, A., Redd, R. A., Lawrence, M. S., Roemer, M. G. M., Li, A. J., Ziepert, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0016-8 · Cited by 1,941
Stromal Gene Signatures in Large-B-Cell Lymphomas
Lenz, G., Wright, G., Dave, S. S., Xiao, W., Powell, J., Zhao, H., Xu, W., Tan, B., Goldschmidt, N., Iqbal, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802885 · Cited by 1,808
Self-citationChronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
Davis, R. E., Ngo, V. N., Lenz, G., Tolar, P., Young, R. M., Romesser, P. B., Kohlhammer, H., Lamy, L., Zhao, H., Yang, Y., et al. (2010) · Nature · doi:10.1038/nature08638 · Cited by 1,643
Self-citationFrequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Morin, R. D., Mendez-Lago, M., Mungall, A. J., Goya, R., Mungall, K. L., Corbett, R. D., Johnson, N. A., Severson, T. M., Chiu, R., Field, M., et al. (2011) · Nature · doi:10.1038/nature10351 · Cited by 1,614
Oncogenically active MYD88 mutations in human lymphoma
Ngo, V. N., Young, R. M., Schmitz, R., Jhavar, S., Xiao, W., Lim, K.-H., Kohlhammer, H., Xu, W., Yang, Y., Zhao, H., et al. (2011) · Nature · doi:10.1038/nature09671 · Cited by 1,512
Self-citationWright, G. W., Huang, D. W., Phelan, J. D., Coulibaly, Z. A., Roulland, S., Young, R. M., Wang, J. Q., Schmitz, R., Morin, R. D., Tang, J., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.015 · Cited by 1,169
Self-citationTargeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wilson, W. H., Young, R. M., Schmitz, R., Yang, Y., Pittaluga, S., Wright, G., Lih, C.-J., Williams, P. M., Shaffer, A. L., Gerecitano, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3884 · Cited by 1,113
Self-citationGenetic and functional drivers of diffuse large B cell lymphoma
Reddy, A., Zhang, J., Davis, N. S., Moffitt, A. B., Love, C. L., Waldrop, A., Leppa, S., Pasanen, A., Meriranta, L., Karjalainen-Lindsberg, M.-L., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.027 · Cited by 1,104
Wright, G., Tan, B., Rosenwald, A., Hurt, E. H., Wiestner, A., & Staudt, L. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732008100 · Cited by 1,040
Self-citationLohr, J. G., Stojanov, P., Lawrence, M. S., Auclair, D., Chapuy, B., Sougnez, C., Cruz-Gordillo, P., Knoechel, B., Asmann, Y. W., Slager, S. L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121343109 · Cited by 974
Analysis of the coding genome of diffuse large B-cell lymphoma
Pasqualucci, L., Trifonov, V., Fabbri, G., Ma, J., Rossi, D., Chiarenza, A., Wells, V. A., Grunn, A., Messina, M., Elliot, O., et al. (2011) · Nature Genetics · doi:10.1038/ng.892 · Cited by 971
Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma
Lenz, G., Davis, R. E., Ngo, V. N., Lam, L., George, T. C., Wright, G. W., Dave, S. S., Zhao, H., Xu, W., Rosenwald, A., et al. (2008) · Science · doi:10.1126/science.1153629 · Cited by 867
Self-citationShaffer, A. L., Yu, X., He, Y., Boldrick, J., Chan, E. P., & Staudt, L. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)00020-0 · Cited by 724
Self-citationYounes, A., Sehn, L. H., Johnson, P., Zinzani, P. L., Hong, X., Zhu, J., Patti, C., Belada, D., Samoilova, O., Suh, C., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02403 · Cited by 608
Self-citationTargetable genetic features of primary testicular and primary central nervous system lymphomas
Chapuy, B., Roemer, M. G. M., Stewart, C., Tan, Y., Abo, R. P., Zhang, L., Dunford, A. J., Meredith, D. M., Thorner, A. R., Jordanova, E. S., et al. (2016) · Blood · doi:10.1182/blood-2015-10-673236 · Cited by 585
Genetic heterogeneity of diffuse large B-cell lymphoma
Zhang, J., Grubor, V., Love, C. L., Banerjee, A., Richards, K. L., Mieczkowski, P. A., Dunphy, C., Choi, W., Au, W. Y., Srivastava, G., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205299110 · Cited by 527
Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
Yang, Y., Shaffer, A. L., Emre, N. C. T., Ceribelli, M., Zhang, M., Wright, G., Xiao, W., Powell, J., Platig, J., Kohlhammer, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.024 · Cited by 521
Self-citationInhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma
Lionakis, M. S., Dunleavy, K., Roschewski, M., Widemann, B. C., Butman, J. A., Schmitz, R., Yang, Y., Cole, D. E., Melani, C., Higham, C. S., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.04.012 · Cited by 508
Self-citationLacy, S. E., Barrans, S. L., Beer, P. A., Painter, D., Smith, A. G., Roman, E., Cooke, S. L., Ruiz, C., Glover, P., Van Hoppe, S. J. L., et al. (2020) · Blood · doi:10.1182/blood.2019003535 · Cited by 506
Scherer, F., Kurtz, D. M., Newman, A. M., Stehr, H., Craig, A. F. M., Esfahani, M. S., Lovejoy, A. F., Chabon, J. J., Klass, D. M., Liu, C. L., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aai8545 · Cited by 484
Roles of BCL6 in normal and transformed germinal center B cells
Basso, K., & Dalla‐Favera, R. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01112.x · Cited by 429
Ennishi, D., Jiang, A., Boyle, M., Collinge, B., Grande, B. M., Ben-Neriah, S., Rushton, C., Tang, J., Thomas, N., Slack, G. W., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01583 · Cited by 414
Victora, G. D., Dominguez-Sola, D., Holmes, A. B., Deroubaix, S., Dalla-Favera, R., & Nussenzweig, M. C. (2012) · Blood · doi:10.1182/blood-2012-03-415380 · Cited by 411
A multiprotein supercomplex controlling oncogenic signalling in lymphoma
Phelan, J. D., Young, R. M., Webster, D. E., Roulland, S., Wright, G. W., Kasbekar, M., Shaffer, A. L., Ceribelli, M., Wang, J. Q., Schmitz, R., et al. (2018) · Nature · doi:10.1038/s41586-018-0290-0 · Cited by 398
Self-citationMutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing
Morin, R. D., Mungall, K., Pleasance, E., Mungall, A. J., Goya, R., Huff, R. D., Scott, D. W., Ding, J., Roth, A., Chiu, R., et al. (2013) · Blood · doi:10.1182/blood-2013-02-483727 · Cited by 390
Mathews Griner, L. A., Guha, R., Shinn, P., Young, R. M., Keller, J. M., Liu, D., Goldlust, I. S., Yasgar, A., McKnight, C., Boxer, M. B., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311846111 · Cited by 377
Self-citationSpina, V., Bruscaggin, A., Cuccaro, A., Martini, M., Di Trani, M., Forestieri, G., Manzoni, M., Condoluci, A., Arribas, A., Terzi-Di-Bergamo, L., et al. (2018) · Blood · doi:10.1182/blood-2017-11-812073 · Cited by 332
Ennishi, D., Takata, K., Béguelin, W., Duns, G., Mottok, A., Farinha, P., Bashashati, A., Saberi, S., Boyle, M., Meissner, B., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1090 · Cited by 318
Sha, C., Barrans, S., Cucco, F., Bentley, M. A., Care, M. A., Cummin, T., Kennedy, H., Thompson, J. S., Uddin, R., Worrillow, L., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01314 · Cited by 300
Diffuse large B-cell lymphoma genotyping on the liquid biopsy
Rossi, D., Diop, F., Spaccarotella, E., Monti, S., Zanni, M., Rasi, S., Deambrogi, C., Spina, V., Bruscaggin, A., Favini, C., et al. (2017) · Blood · doi:10.1182/blood-2016-05-719641 · Cited by 256
Béguelin, W., Teater, M., Gearhart, M. D., Calvo Fernández, M. T., Goldstein, R. L., Cárdenas, M. G., Hatzi, K., Rosen, M., Shen, H., Corcoran, C. M., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.07.006 · Cited by 254
Oncogenic Mechanisms in Burkitt Lymphoma
Schmitz, R., Ceribelli, M., Pittaluga, S., Wright, G., & Staudt, L. M. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014282 · Cited by 245
Self-citationA library of gene expression signatures to illuminate normal and pathological lymphoid biology
Shaffer, A. L., Wright, G., Yang, L., Powell, J., Ngo, V., Lamy, L., Lam, L. T., Davis, R. E., & Staudt, L. M. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00373.x · Cited by 228
Self-citationRecurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas
Nakamura, T., Tateishi, K., Niwa, T., Matsushita, Y., Tamura, K., Kinoshita, M., Tanaka, K., Fukushima, S., Takami, H., Arita, H., et al. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12259 · Cited by 227
Braggio, E., Van Wier, S., Ojha, J., McPhail, E., Asmann, Y. W., Egan, J., da Silva, J. A., Schiff, D., Lopes, M. B., Decker, P. A., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2116 · Cited by 222
Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas
Morin, R. D., Assouline, S., Alcaide, M., Mohajeri, A., Johnston, R. L., Chong, L., Grewal, J., Yu, S., Fornika, D., Bushell, K., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2123 · Cited by 221
Johnson, J. L., Rosenthal, R. L., Knox, J. J., Myles, A., Naradikian, M. S., Madej, J., Kostiv, M., Rosenfeld, A. M., Meng, W., Christensen, S. R., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.03.020 · Cited by 212
Dubois, S., Viailly, P.-J., Mareschal, S., Bohers, E., Bertrand, P., Ruminy, P., Maingonnat, C., Jais, J.-P., Peyrouze, P., Figeac, M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2305 · Cited by 200
Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens
Young, R. M., Wu, T., Schmitz, R., Dawood, M., Xiao, W., Phelan, J. D., Xu, W., Menard, L., Meffre, E., Chan, W.-C. C., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1514944112 · Cited by 191
Self-citationGenomic characterization of primary central nervous system lymphoma
Fukumura, K., Kawazu, M., Kojima, S., Ueno, T., Sai, E., Soda, M., Ueda, H., Yasuda, T., Yamaguchi, H., Lee, J., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1536-2 · Cited by 188
Hatzi, K., Jiang, Y., Huang, C., Garrett-Bakelman, F., Gearhart, M. D., Giannopoulou, E. G., Zumbo, P., Kirouac, K., Bhaskara, S., Polo, J. M., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.06.016 · Cited by 187
Mutational analysis of primary central nervous system lymphoma
Bruno, A., Boisselier, B., Labreche, K., Marie, Y., Polivka, M., Jouvet, A., Adam, C., Figarella-Branger, D., Miquel, C., Eimer, S., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2080 · Cited by 185
Breaking bad in the germinal center: how deregulation of BCL6 contributes to lymphomagenesis
Hatzi, K., & Melnick, A. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.03.001 · Cited by 183
Karube, K., Enjuanes, A., Dlouhy, I., Jares, P., Martin-Garcia, D., Nadeu, F., Ordóñez, G. R., Rovira, J., Clot, G., Royo, C., et al. (2018) · Leukemia · doi:10.1038/leu.2017.251 · Cited by 179
Self-citationPathogenic B‐cell receptor signaling in lymphoid malignancies: New insights to improve treatment
Young, R. M., Phelan, J. D., Wilson, W. H., & Staudt, L. M. (2019) · Immunological Reviews · doi:10.1111/imr.12792 · Cited by 172
Self-citationVater, I., Montesinos-Rongen, M., Schlesner, M., Haake, A., Purschke, F., Sprute, R., Mettenmeyer, N., Nazzal, I., Nagel, I., Gutwein, J., et al. (2015) · Leukemia · doi:10.1038/leu.2014.264 · Cited by 166
Kataoka, K., Miyoshi, H., Sakata, S., Dobashi, A., Couronné, L., Kogure, Y., Sato, Y., Nishida, K., Gion, Y., Shiraishi, Y., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0380-5 · Cited by 164
Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma
Arthur, S. E., Jiang, A., Grande, B. M., Alcaide, M., Cojocaru, R., Rushton, C. K., Mottok, A., Hilton, L. K., Lat, P. K., Stutheit-Zhao, E. Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06354-3 · Cited by 148
Maurer, M. J., Ghesquières, H., Link, B. K., Jaïs, J., Habermann, T. M., Thompson, C. A., Haïoun, C., Allmer, C., Johnston, P. B., Delarue, R., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.5198 · Cited by 147
Dubois, S., Viailly, P., Bohers, É., Bertrand, P., Ruminy, P., Marchand, V., Maingonnat, C., Mareschal, S., Picquenot, J., Penther, D., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1922 · Cited by 134
de Miranda, N. F. C. C., Georgiou, K. E., Chen, L., Wu, C., Gao, Z., Zaravinos, A., Lisboa, S., Enblad, G., Teixeira, M. R., Zeng, Y., et al. (2014) · Blood · doi:10.1182/blood-2013-12-546309 · Cited by 133
TBL1XR1 mutations drive extranodal lymphoma by inducing a pro-tumorigenic memory fate
Venturutti, L., Teater, M., Zhai, A., Chadburn, A., Babiker, L., Kim, D., Béguelin, W., Lee, T. C., Kim, Y., Chin, C. R., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.049 · Cited by 127
Self-citationDistinct molecular profile of IRF4-rearranged large B-cell lymphoma
Ramis-Zaldivar, J. E., González‐Farré, B., Balagué, O., Celis, V., Nadeu, F., Salmerón‐Villalobos, J., Andrés, M., Martín‐Guerrero, I., Garrido‐Pontnou, M., Gaafar, A., et al. (2019) · Blood · doi:10.1182/blood.2019002699 · Cited by 126
Mareschal, S., Pham‐Ledard, A., Viailly, P., Dubois, S., Bertrand, P., Maingonnat, C., Fontanilles, M., Bohers, É., Ruminy, P., Tournier, I., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.04.010 · Cited by 117
Bohers, É., Viailly, P., Becker, S., Marchand, V., Ruminy, P., Maingonnat, C., Bertrand, P., Etancelin, P., Picquenot, J., Camus, V., et al. (2018) · Blood Cancer Journal · doi:10.1038/s41408-018-0111-6 · Cited by 116
Fontanilles, M., Marguet, F., Bohers, É., Viailly, P., Dubois, S., Bertrand, P., Camus, V., Mareschal, S., Ruminy, P., Maingonnat, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18325 · Cited by 103
Mareschal, S., Dubois, S., Viailly, P., Bertrand, P., Bohers, É., Maingonnat, C., Jaïs, J., Tesson, B. M., Ruminy, P., Peyrouze, P., et al. (2015) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22328 · Cited by 99
Juškevičius, D., Lorber, T., Gsponer, J. R., Perrina, V., Ruiz, C. F., Stenner, F., Dirnhofer, S., & Tzankov, A. (2016) · Leukemia · doi:10.1038/leu.2016.135 · Cited by 99
Chapuy, B., Cheng, H., Watahiki, A., Ducar, M. D., Tan, Y., Chen, L., Roemer, M. G. M., Ouyang, J., Christie, A. L., Zhang, L., et al. (2016) · Blood · doi:10.1182/blood-2015-09-672352 · Cited by 93
Mutational landscape of B‐cell post‐transplant lymphoproliferative disorders
Menter, T., Juškevičius, D., Alikian, M., Steiger, J., Dirnhofer, S., Tzankov, A., & Naresh, K. N. (2017) · British Journal of Haematology · doi:10.1111/bjh.14633 · Cited by 82
Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma
Ma, M. C. J., Tadros, S., Bouska, A. C., Heavican, T. B., Yang, H., Deng, Q., Moore, D. Y., Akhter, A., Hartert, K. T., Jain, N. K., et al. (2021) · Haematologica · doi:10.3324/haematol.2020.274258 · Cited by 81
Juškevičius, D., Jucker, D., Klingbiel, D., Mamot, C., Dirnhofer, S., & Tzankov, A. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0438-7 · Cited by 76
Zhou, X. A., Louissaint, A., Wenzel, A. T., Yang, J., Martínez‐Escala, M. E., Moy, A. P., Morgan, E. A., Paxton, C. N., Hong, B., Andersen, E., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.04.038 · Cited by 70
Liquid biopsy for the identification of intravascular large B-cell lymphoma
Suehara, Y., Sakata‐Yanagimoto, M., Hattori, K., Nanmoku, T., Itoh, T., Kaji, D., Yamamoto, G., Abe, Y., Narita, K., Takeuchi, M., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.178830 · Cited by 67
Runge, H. F. P., Lacy, S., Barrans, S., Beer, P. A., Painter, D., Smith, A. G., Roman, E., Burton, C., Crouch, S., Tooze, R. M., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.17132 · Cited by 65
T-Bet+ IgM Memory Cells Generate Multi-lineage Effector B Cells
Kenderes, K. J., Levack, R. C., Papillion, A. M., Cabrera-Martinez, B., Dishaw, L. M., & Winslow, G. M. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.074 · Cited by 63
Zhou, Y., Liu, W., Xu, Z., Zhu, H., Xiao, D., Su, W., Zeng, R., Feng, Y., Duan, Y., Zhou, J., et al. (2018) · Neoplasia · doi:10.1016/j.neo.2018.08.012 · Cited by 61
Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma
Park, H. Y., Lee, S., Yoo, H.-Y., Kim, S.-J., Kim, W.-S., Kim, J., & Ko, Y. H. (2016) · Oncotarget · doi:10.18632/oncotarget.13239 · Cited by 54
Ducharme, O., Beylot-Barry, M., Pham‐Ledard, A., Bohers, É., Viailly, P., Bandres, T., Faur, N., Frison, É., Vergier, B., Jardin, F., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.05.008 · Cited by 41
Greenawalt, D. M., Liang, W. S., Saif, S., Johnson, J. H., Todorov, P. V., Dulak, A. M., Enríquez, D., Halperin, R. F., Ahmed, A., Saveliev, V. N., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18502 · Cited by 36
Shin, S., Kim, Y. J., Lee, D., Cho, D., Ko, Y. H., Cho, J., Park, W., Park, D., Kim, S. J., & Kim, W. S. (2019) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2019.1573998 · Cited by 36
Vela, V., Juškevičius, D., Gerlach, M. M., Meyer, P., Graber, A., Cathomas, G., Dirnhofer, S., & Tzankov, A. (2020) · Hematological Oncology · doi:10.1002/hon.2718 · Cited by 36
Intlekofer, A. M., Joffe, E., Batlevi, C. L., Hilden, P., He, J., Seshan, V. E., Zelenetz, A. D., Palomba, M. L., Moskowitz, C. H., Portlock, C., et al. (2018) · Blood Cancer Journal · doi:10.1038/s41408-018-0089-0 · Cited by 35
Wist, M., Meier, L., Gutman, O., Haas, J., Endres, S., Zhou, Y., Rösler, R., Wiese, S., Stilgenbauer, S., Hobeika, E., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011946 · Cited by 34
Mutational profile of primary breast diffuse large B-cell lymphoma
Franco, F., González‐Rincón, J., Lavernia, J., García, J. F., Martín, P., Bellas, C., Piris, M. A., Pedrosa, L., Miramón, J., Gómez‐Codina, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21986 · Cited by 31
Dobashi, A., Togashi, Y., Tanaka, N., Yokoyama, M., Tsuyama, N., Baba, S., Mori, S., Hatake, K., Yamaguchi, T., Noda, T., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24656 · Cited by 27
Hattori, K., Sakata‐Yanagimoto, M., Kusakabe, M., Nanmoku, T., Suehara, Y., Matsuoka, R., Noguchi, M., Yokoyama, Y., Kato, T., Kurita, N., et al. (2018) · Cancer Science · doi:10.1111/cas.13848 · Cited by 21
Mishina, T., Oshima‐Hasegawa, N., Tsukamoto, S., Fukuyo, M., Kageyama, H., Muto, T., Mimura, N., Rahmutulla, B., Nagai, Y., Kayamori, K., et al. (2021) · British Journal of Haematology · doi:10.1111/bjh.17765 · Cited by 21
Hoshino, H., Nishino, T. G., Tashiro, S., Miyazaki, M., Ohmiya, Y., Igarashi, K., Horinouchi, S., & Yoshida, M. (2007) · The Journal of Biochemistry · doi:10.1093/jb/mvm073 · Cited by 17
Cited by
Campo, E., Jaffe, E. S., Cook, J. R., Quintanilla-Martinez, L., Swerdlow, S. H., Anderson, K. C., Brousset, P., Cerroni, L., de Leval, L., Dirnhofer, S., et al. (2022) · Blood · doi:10.1182/blood.2022015851 · Cited by 1,608
Self-citationNakhoda, S., Vistarop, A., & Wang, Y. L. (2023) · British Journal of Haematology · doi:10.1111/bjh.18418 · Cited by 104
Zhang, D., Harris, H. M., Chen, J., Judy, J., James, G., Kelly, A., McIntosh, J., Tenn-McClellan, A., Ambing, E., Tan, Y. S., et al. (2023) · Blood · doi:10.1182/blood.2022016934 · Cited by 35
Drug-Loaded Biomimetic Carriers for Non-Hodgkin’s Lymphoma Therapy: Advances and Perspective
Li, X., Zhang, Y., Wang, C., Wang, L., Ye, Y., Xue, R., Shi, Y., Su, Q., Zhu, Y., & Wang, L. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c01480 · Cited by 4
Metadata
- Authors
- Wilson, W. H., Wright, G. W., Huang, D. W., Hodkinson, B., Balasubramanian, S., Fan, Y., Vermeulen, J., Shreeve, M., & Staudt, L. M.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2021-12
- Volume
- 39
- Issue
- 12
- Pages
- 1643-1653.e3
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W3209622492
- Cited by
- 315
- References
- 85
- FWCI
- 30.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.